Verily, Alphabet Inc.'s health technology subsidiary, announced Thursday it will sell its stop-loss insurance business, Granular Insurance Company, to Elevance Health.
Oppenheimer analyst Jason Helfstein maintained an Outperform rating and raised the price target from $215 to $225 on Jan. 30, 2025. This analyst has an accuracy rate of 80%. Scotiabank analyst Nat ...